Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

LEAD SUPERVISOR: Professor Chris Schofield, Department of Chemistry

Co-supervisor: Professor Fernanda Duarte, Department of Chemistry

Commercial partner: Ineos / Ineos Oxford `Institute for Antimicrobial Resistance (IOI), Oxford


 Tetracycline type antibacterials are a mainstay of modern medicine and are also widely used in farming. However, their use is increasingly compromised by resistance, including by the Tet-X enzymes which are the mechanistically interesting flavin dependent monoxygenases. Whilst work with the beta-lactam antibiotics, such as the pencillins and cephalosporins, has shown the clinical utility of protecting them from enzyme mediated resistance by use of an inhibitor in a combination therapies (e.g. Augmentin = penicillin + clavulanic acid, a beta-lactamase inhibitor), this approach is largely unexplored for other antibacterial classes, such as tetracyclines,  including new generation compounds such as tigecycline. The project will aim to address this by enabling the development of inhibitors of the Tet-X enzymes. The project will involve assay development, structural (including high-throughput and time resolved methods) and mechanistic studies, and inhibitor design / screening / synthesis, with the precise focus depending on the interests of the particular student.


Apply using course: DPhil in Organic Chemistry


January 2023 update:

Applications for this iCASE project (for October 2023 entry) are no longer accepted.

MRC logo